One-Year Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Muthiah Vaduganathan1, Ran Kornowski2, Arman Qamar1

  • 1Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts.

Insights

Coronary artery calcium (CAC) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI) is linked to worse outcomes. However, advanced CAC was not an independent predictor of 1-year mortality after adjusting for other factors.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Coronary artery calcium (CAC) is a known predictor of adverse events after percutaneous coronary intervention (PCI).
  • Limited data exist on the long-term impact of angiographically evident CAC in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary PCI.

Purpose of the Study:

  • To investigate the association between moderate-to-severe CAC and 1-year all-cause mortality in STEMI patients after primary PCI.
  • To determine if CAC independently predicts long-term outcomes in this patient population.

Main Methods:

  • Retrospective analysis of 2,143 consecutive STEMI patients undergoing primary PCI.
  • Patients categorized by visual assessment of CAC: moderate-to-severe (n=306) vs. minimal-to-none (n=1,837).
  • Primary endpoint: all-cause mortality at 1-year post-PCI, with multivariable adjustment for clinical and angiographic factors.

Main Results:

  • Moderate-to-severe CAC was associated with older age, female sex, and comorbidities like hypertension and chronic kidney disease.
  • Patients with moderate-to-severe CAC had higher rates of anterior MI, advanced Killip class, and poorer angiographic results.
  • Unadjusted 1-year mortality was higher in the moderate-to-severe CAC group (8.5% vs. 4.7%, p=0.008).
  • After adjustment, moderate-to-severe CAC was not an independent predictor of 1-year all-cause mortality.

Conclusions:

  • Approximately 15% of STEMI patients undergoing primary PCI exhibit moderate-to-severe CAC.
  • While associated with adverse clinical and angiographic features, advanced CAC is not an independent predictor of 1-year mortality in STEMI patients post-PCI.
  • CAC may serve as a marker of overall cardiovascular risk in STEMI patients, but its independent prognostic value for mortality requires further investigation.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
714
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
374
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
386
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
629